Pharma Journalist -

Glenmark Pharmaceuticals S.A. and Harbour BioMed announced that they have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and…
Read More...

Abzena plc has entered into a master service agreement with one of America’s leading academic medical centres, NYU Langone Health (New York, US). The agreement, for protein engineering…
Read More...

AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, US (known as MSD outside the US and Canada) announced that the European Medicines Agency (EMA) has granted orphan designation to…
Read More...

Amgen announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus. The new plant is the first-of-its-kind…
Read More...

PTC Therapeutics and Akcea Therapeutic an affiliate of Ionis Pharmaceuticals announced a collaboration under which PTC will commercialize two of Akcea's rare disease drugs in Latin…
Read More...

Roche announced that the European Medicines Agency (EMA) has granted PRIME (PRIority MEdicines) designation for the company’s investigational medicine RG6042 (formerly known as…
Read More...

Novartis announced that the European Commission (EC) approved Aimovig (erenumab) for the prevention of migraine in adults experiencing four or more migraine days per month. Aimovig is…
Read More...

AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, US (known as MSD outside the US and Canada) announced that the European Medicines Agency (EMA) has granted orphan designation to…
Read More...

Takeda Pharmaceutical Company Limited announced the opening of a production site for NINLARO (ixazomib), an innovative drug for patients with multiple myeloma, at its Yaroslavl plant.…
Read More...

Pfizer Inc. announced the European Commission (EC) has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor (HER2)…
Read More...